B.E. Persson

728 total citations
27 papers, 549 citations indexed

About

B.E. Persson is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, B.E. Persson has authored 27 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in B.E. Persson's work include Prostate Cancer Treatment and Research (12 papers), Cancer, Lipids, and Metabolism (6 papers) and Hormonal and reproductive studies (6 papers). B.E. Persson is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Cancer, Lipids, and Metabolism (6 papers) and Hormonal and reproductive studies (6 papers). B.E. Persson collaborates with scholars based in Sweden, United States and Denmark. B.E. Persson's co-authors include K. R. Spring, Robert S. Fisher, Å Fritjofsson, Magnus Fall, Mirja Ruutu, Olbjørn Klepp, L Wahlqvist, Anna E. Stenwig, Arne M. Olsson and Nina Aass and has published in prestigious journals such as Science, Journal of Clinical Oncology and The Journal of Urology.

In The Last Decade

B.E. Persson

25 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.E. Persson Sweden 10 200 177 136 113 88 27 549
Noritaka Kamimura Japan 15 158 0.8× 305 1.7× 136 1.0× 117 1.0× 47 0.5× 49 571
Dũng Chí Vũ Vietnam 16 247 1.2× 187 1.1× 181 1.3× 17 0.2× 32 0.4× 35 857
J.J. van der Harten Netherlands 13 548 2.7× 123 0.7× 46 0.3× 26 0.2× 61 0.7× 27 903
Frank‐Mattias Schäfer Germany 14 218 1.1× 125 0.7× 90 0.7× 42 0.4× 12 0.1× 31 542
G. Fekete Hungary 12 281 1.4× 39 0.2× 48 0.4× 39 0.3× 47 0.5× 32 490
Placido B. Grino United States 9 311 1.6× 24 0.1× 212 1.6× 204 1.8× 94 1.1× 12 697
Wenwei Wang China 12 115 0.6× 122 0.7× 29 0.2× 43 0.4× 40 0.5× 27 488
Ryszard Ślężak Poland 13 155 0.8× 62 0.4× 35 0.3× 15 0.1× 121 1.4× 50 472
Peter J. Gkonos United States 15 203 1.0× 47 0.3× 130 1.0× 21 0.2× 12 0.1× 20 568
V. Cusí Spain 17 217 1.1× 168 0.9× 89 0.7× 21 0.2× 21 0.2× 38 703

Countries citing papers authored by B.E. Persson

Since Specialization
Citations

This map shows the geographic impact of B.E. Persson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.E. Persson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.E. Persson more than expected).

Fields of papers citing papers by B.E. Persson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.E. Persson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.E. Persson. The network helps show where B.E. Persson may publish in the future.

Co-authorship network of co-authors of B.E. Persson

This figure shows the co-authorship network connecting the top 25 collaborators of B.E. Persson. A scholar is included among the top collaborators of B.E. Persson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.E. Persson. B.E. Persson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crawford, E. David, Bertrand Tombal, Thomas E. Keane, et al.. (2018). FSH suppression and tumour control in patients with prostate cancer during androgen deprivation with a GnRH agonist or antagonist. Scandinavian Journal of Urology. 52(5-6). 349–357. 18 indexed citations
2.
Tombal, Bertrand, Fritz H. Schröder, K. Miller, Egbert van der Meulen, & B.E. Persson. (2011). 1088 LONG-TERM PROSTATE-SPECIFIC ANTIGEN (PSA) CONTROL IN PROSTATE CANCER: CONTINUOUS DEGARELIX OR DEGARELIX FOLLOWING LEUPROLIDE. European Urology Supplements. 10(2). 335–335. 4 indexed citations
3.
Rosette, Jean de la, Ronald L. Davis, B.E. Persson, & Tine Kold Olesen. (2010). 139 EVALUATION OF THE EFFICACY AND SAFETY OF SWITCHING FROM TREATMENT WITH LEUPROLIDE 1-MONTH DOSING REGIMEN TO DEGARELIX 1-MONTH DOSING REGIMEN IN PROSTATE CANCER (PCA) PATIENTS. European Urology Supplements. 9(2). 76–76.
4.
Boccon-Gibod, L, et al.. (2009). 7015 Degarelix versus leuprolide in patients with metastatic prostate cancer: assessment of serum alkaline phosphatase over time. European Journal of Cancer Supplements. 7(2). 411–411. 2 indexed citations
5.
Tombal, Bertrand, K. Miller, L Boccon-Gibod, et al.. (2009). 38 DEGARELIX VS. LEUPROLIDE TREATMENT IN PATIENTS WITH ADVANCED PROSTATE CANCER: PSA FAILURES DURING A RANDOMISED, PHASE III TRIAL (CS21). European Urology Supplements. 8(4). 130–130. 4 indexed citations
6.
Damber, J.‐E., Teuvo L.J. Tammela, Per‐Anders Abrahamsson, et al.. (2009). 39 COMPARING TESTOSTERONE AND PSA FOR DIFFERENT BASELINE TESTOSTERONE CONCENTRATIONS DURING INITIATION OF DEGARELIX AND LEUPROLIDE TREATMENT. European Urology Supplements. 8(4). 130–130. 5 indexed citations
7.
Klotz, Laurence, Henrik Daa Schrøder, B.E. Persson, et al.. (2008). DEGARELIX COMPARED TO LEUPROLIDE DEPOT 7.5 MG IN A 12- MONTH RANDOMISED, OPEN-LABEL, PARALLEL-GROUP PHASE III STUDY IN PROSTATE CANCER PATIENTS. European Urology Supplements. 7(3). 205–205. 7 indexed citations
8.
Lottmann, H., Frank M.J.A. Froeling, S. Alloussi, et al.. (2007). A randomised comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis. International Journal of Clinical Practice. 61(9). 1454–1460. 63 indexed citations
9.
Poppel, Hendrik Van, Jean J. de la Rosette, B.E. Persson, & Tine Kold Olesen. (2007). 23 LONG-TERM EVALUATION OF DEGARELIX, A GONADOTROPHIN-RELEASING HORMONE (GNRH) RECEPTOR BLOCKER, INVESTIGATED IN A MULTICENTRE RANDOMISED STUDY IN PROSTATE CANCER (CAP) PATIENTS. European Urology Supplements. 6(2). 28–28. 1 indexed citations
10.
Iversen, Pernille, Hendrik Van Poppel, Teuvo L.J. Tammela, et al.. (2006). MP-08.18. Urology. 68. 102–102. 2 indexed citations
11.
Xia, Peng, B.E. Persson, & K. R. Spring. (1995). The chloride concentration in the lateral intercellular spaces of MDCK cell monolayers. The Journal of Membrane Biology. 144(1). 21–30. 10 indexed citations
12.
Roomans, Godfried M., et al.. (1993). Structural and functional studies of gap junctions in human myometrium.. PubMed. 31(1-2). 55–9. 5 indexed citations
13.
Lindgren, Fredrik, S. G. Hartling, Gisela Dahlquist, et al.. (1991). Glucose‐induced Insulin Response is Reduced and Proinsulin Response Increased in Healthy Siblings of Type 1 Diabetic Patients. Diabetic Medicine. 8(7). 638–643. 17 indexed citations
14.
Persson, B.E., et al.. (1991). Uridine, Xanthine and Urate Concentrations in Prostatic Fluid and Seminal Plasma of Patients with Prostatitis. European Urology. 19(3). 253–256. 15 indexed citations
15.
Klepp, Olbjørn, Arne M. Olsson, Hannah Henrikson, et al.. (1990). Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group.. Journal of Clinical Oncology. 8(3). 509–518. 123 indexed citations
16.
Persson, B.E., et al.. (1988). Juxtaglomerular interstitial hypertonicity in Amphiuma: tubular origin-TGF signal. American Journal of Physiology-Renal Physiology. 254(3). F445–F449. 20 indexed citations
17.
Fritjofsson, Å, et al.. (1987). Treatment of Ulcer and Nonulcer Interstitial Cystitis with Sodium Pentosanpolysulfate: A Multicenter Trial. The Journal of Urology. 138(3). 508–512. 69 indexed citations
18.
Persson, B.E. & Donald J. Marsh. (1987). GFR regulation and flow-dependent electrophysiology of early distal tubule in Amphiuma. American Journal of Physiology-Renal Physiology. 253(2). F263–F268. 8 indexed citations
19.
Persson, B.E. & K. R. Spring. (1982). Gallbladder epithelial cell hydraulic water permeability and volume regulation.. The Journal of General Physiology. 79(3). 481–505. 113 indexed citations
20.
Fisher, Robert S., B.E. Persson, & K. R. Spring. (1981). Epithelial Cell Volume Regulation: Bicarbonate Dependence. Science. 214(4527). 1357–1359. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noritaka Kamimura Breakdown of academic impact, for papers by Dũng Chí Vũ Breakdown of academic impact, for papers by J.J. van der Harten Breakdown of academic impact, for papers by Frank‐Mattias Schäfer Breakdown of academic impact, for papers by G. Fekete Breakdown of academic impact, for papers by Placido B. Grino Breakdown of academic impact, for papers by Wenwei Wang Breakdown of academic impact, for papers by Ryszard Ślężak Breakdown of academic impact, for papers by Peter J. Gkonos Breakdown of academic impact, for papers by V. Cusí
Rankless by CCL
2026